Reducing carbon footprint by switching to reusable soft-mist inhalers

OBJECTIVE: Inhalation therapy is the cornerstone of COPD, together with non-pharmacological treatments. Long-acting muscarinic antagonists (LAMAs), alone or in combination with long-acting β-agonists (LABAs), are commonly used. Pressurised metered-dose inhalers (pMDIs), dry powder inhalers (DPIs) an...

Descripción completa

Detalles Bibliográficos
Autores principales: Janson, Christer, Hernando Platz, Jaime, Soulard, Stéphane, Langham, Sue, Nicholson, Lindsay, Hartgers-Gubbels, Elisabeth Sophia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2023
Materias:
Original research articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10152248/
https://www.ncbi.nlm.nih.gov/pubmed/37143844
http://dx.doi.org/10.1183/23120541.00543-2022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10152248/
https://www.ncbi.nlm.nih.gov/pubmed/37143844
http://dx.doi.org/10.1183/23120541.00543-2022

Ejemplares similares